Watch CBS News
The Food and Drug Administration authorized expanded access to booster shots of Pfizer's COVID-19 vaccine for people aged 65 and up as well as those with weakened immune systems and adults whose job or living situation frequently exposes them to the virus. It's now up to the Centers for Disease Control and Prevention to decide how and when the shots will be distributed. CBS News' Bradley Blackburn joins CBSN AM to discuss.
The Food and Drug Administration granted emergency-use authorization for booster shots of Pfizer's COVID-19 vaccine for seniors and other people considered to be high-risk, a scaled-down version of President Biden's original plan for the additional shots. Meanwhile, Mr. Biden met with Democratic lawmakers on a $3.5 trillion spending bill. CBS News senior White House correspondent Weijia Jiang joins CBSN AM with more.
Third doses could roll out this week, pending a review by CDC advisers
Johnson & Johnson said a second dose of its one-shot COVID vaccine offers stronger protection against the disease. Mark Strassmann has the latest.
The company says it will seek U.S. approval for that age group soon. One board member says if all goes well, the green light could come "as early as around Halloween."
Pfizer said its COVID vaccine is safe and effective at a lower dose for children 5 to 11 years old. The company is hoping the shots will be available by the end of October. Mola Lenghi reports.
Pfizer says a smaller dose of its COVID-19 vaccine is safe and effective in children ages 5 to 11. The company will submit its findings to the FDA for review. CBS News correspondent Mola Lenghi reports on the details, and then pediatrician Dr. Rashmi Jain joins CBSN to discuss what it will mean for families.
President Biden’s plan to give booster shots to most Americans was rejected by an FDA advisory panel just days before its rollout. The panel did, however, endorse a Pfizer booster shot for older Americans or those at risk of serious disease. Jonathan Vigliotti has the latest.
Pfizer has announced its COVID-19 vaccine showed promising results in children ages 5 to 11 years old. CBS News' Mola Lenghi spoke with one family who was part of the trials, then Dr. Ron Elfenbein joins CBSN AM to talk more about the research and when the vaccine could be available for younger age groups.
Pfizer says early results from its COVID-19 vaccine trial shows its shot is safe and effective for children aged 5 through 11 as cases jump among children. Infectious disease expert Dr. Michael Osterholm joined CBSN with more on the promising new data.
The debate over the necessity of COVID-19 booster shots is becoming yet another point of contention in public health discourse. Meanwhile, there are signs of hope as the U.S. reported two straight weeks of decline in new infections. Anthony Pura reports.
A Food and Drug Administration advisory committee voted to recommend only people over the age of 65 or who are immunocompromised need third doses of the Pfizer vaccine. CBS News correspondent Jonathan Vigliotti reports the decision upends the Biden administration's plans to roll out a mass booster program Monday. Then, Dr. Hilary Fairbrother, an emergency medicine physician, joins CBSN's Lana Zak to explain what this vote means for the future of COVID-19 vaccine boosters.
A Food and Drug Administration advisory committee is expected to vote on the safety and efficacy of a third dose of the Pfizer-BioNTech vaccine. CBS News' Natalie Brand reports on the debate over whether vaccinated Americans need booster shots, and CBS News researcher Max Bayer has more on the FDA hearing.
Amid confusion about whether COVID-19 booster shots are necessary, Dr. Jon LaPook explains what the FDA’s decision on the Pfizer booster shot means and who should be getting them.
Prior to the FDA's announcement Friday that a COVID-19 booster shot is only recommended for some Americans, President Biden planned to begin offering booster shots to the general public as soon as next week. Nancy Cordes has more on how Mr. Biden has softened his position.
The panel had initially rejected by a majority vote over Pfizer's request for full approval of a booster.
The FDA has approved the nation's first COVID-19 vaccine. About 3 million doses of Pfizer's vaccine are expected to be shipped as early as the weekend. Tom Hanson reports on the beginning of what will be the largest vaccination effort in American history.
The White House wants to begin offering COVID-19 booster shots to the general public as soon as next week. An FDA panel is meeting today to debate whether to OK that. CBS News senior White House and political correspondent Ed O'Keefe joined CBSN with more on that plus other issues on the president's agenda.
In August, President Biden announced his plan to get booster shots into arms as early as September 20 to fight back against the coronavirus.
Scientists are debating whether COVID-19 booster shots are necessary for those who are not immunocompromised, with some saying the vaccine is effective enough on its own. An FDA committee will vote Friday whether to approve Pfizer's booster shot. Jonathan Vigliotti reports.
The pandemic continues to devastate the U.S., as 1 in 500 Americans have died from COVID-19, according to Centers for Disease Control and Prevention data. Meanwhile, the country is pushing its vaccination efforts amid talks of implementing possible booster shots. Urgent care nurse practitioner Justin Gill joined CBSN to talk about the latest coronavirus news.
The FDA is not yet taking a definitive stance on whether or not booster shots are needed to help protect people from coronavirus infections. A key advisory committee is set to meet to discuss authorizing an extra dose of Pfizer's vaccine in the coming days. CBS News correspondent Omar Villafranca reports from Tennessee, where first vaccine doses remain low. Then, Dr. Adam Brown, an emergency physician and the COVID-19 national task force chair at Envision Healthcare, joins CBSN's Lana Zak to discuss the latest on the pandemic.
Pfizer and Moderna are pushing for COVID-19 vaccine booster shots, but the Food and Drug Administration has yet to support a third dose. Many Americans still need to be convinced to get their first shot. Omar Villafranca has more.
New research from the Centers for Disease Control and Prevention shows that as of July, unvaccinated people were 10 times more likely to be hospitalized for COVID-19 and 11 times more like to die of it than people who got the vaccine. CDC Director Dr. Rochelle Walensky discussed the findings at a briefing.
Nearly a quarter of all new COVID-19 cases are in children, but the process of getting a vaccine authorized for kids under 12 isn't easy. Wall Street Journal reporter Jared S. Hopkins joins "CBSN AM" to talk about his reporting.
The U.S. Immigration and Customs Enforcement building in Portland has recently been the site of nightly protests.
Congressional leaders traded blame for the government shutdown on Sunday as the stalemate over how to reopen the government stretched into another week without progress on negotiations.
Americans are concerned about effect of shutdown on economy, amid unease about jobs and inflation.
In an interview with CBS News, Justice Amy Coney Barrett said of the Supreme Court's emergency orders in the Trump cases, "This isn't the final decision."
Hurricane Priscilla was strengthening Sunday in the Pacific Ocean, off the southwestern coast of Mexico.
The Cathedral of St. Matthew the Apostle was celebrating the Red Mass, an annual Mass to mark the start of the U.S. Supreme Court term. There were no justices spotted at Sunday's Mass.
Preparing for the threats of tomorrow, the U.S. Air Force is testing drones piloted by artificial intelligence alongside aircraft flown by humans – and is teaching AI how to fight, a potential revolution in warfare.
Rival gunmen started shooting at each other in a crowded downtown nightlife district in Alabama's capital city Saturday night, police said.
Mark Sanchez, who is a Fox Sports analyst, was arrested on multiple misdemeanor charges at an Indianapolis hospital, police said.